{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:25:06Z","timestamp":1791347106103,"version":"4.3.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["mdconsult.com","theclinics.com","derm.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.det.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T08:30:42Z","timestamp":1399278642000},"page":"369-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["The Cutaneous Porphyrias"],"prefix":"10.1016","volume":"32","author":[{"given":"Danja","family":"Schulenburg-Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwani","family":"Katugampola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Badminton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2014.03.001_bib1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.det.2014.03.001_bib2","series-title":"Ein Fall von Pemphigus leprosus complicirt durch Lepra visceralis. Inaugural Dissertation","author":"Schultz","year":"1874"},{"key":"10.1016\/j.det.2014.03.001_bib3","first-page":"1","article-title":"Hydroea aestivale in two brothers complicated with the presence of haematoporphyrin in the urine","volume":"10","author":"Anderson","year":"1898","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib4","first-page":"1","article-title":"Zur pathgenese der hamatoporphyrinurie","volume":"28","author":"Stokvis","year":"1895","journal-title":"Z\u00a0Klin Med"},{"key":"10.1016\/j.det.2014.03.001_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0738-081X(97)00199-5","article-title":"Historical perspective","volume":"16","author":"Goldberg","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib6","first-page":"117","article-title":"Further South African cases of porphyrinuria","volume":"2","author":"Barnes","year":"1951","journal-title":"S\u00a0Afr J Clin Sci"},{"key":"10.1016\/j.det.2014.03.001_bib7","series-title":"The porphyrias: a story of inheritance and environment","first-page":"4","article-title":"Porphyria variegata: a new disease","author":"Dean","year":"1971"},{"key":"10.1016\/j.det.2014.03.001_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.1.5583.7","article-title":"Porphyria in the royal houses of Stuart, Hanover, and Prussia. A follow-up study of George 3d's illness","volume":"1","author":"Macalpine","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.det.2014.03.001_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/jclinpath-2011-200276","article-title":"A\u00a0review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the \u2018Royal Malady\u2019","volume":"65","author":"Hift","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.det.2014.03.001_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1172\/JCI102091","article-title":"Studies of coproporphyrin III. Idiopathic coproporphyrinuria; a hitherto unrecognized form characterized by lack of symptoms in spite of the excretion of large amounts of coproporphyrin","volume":"28","author":"Watson","year":"1949","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.det.2014.03.001_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.2.4931.85","article-title":"Hereditary coproporphyria","volume":"2","author":"Berger","year":"1955","journal-title":"Br Med J"},{"key":"10.1016\/j.det.2014.03.001_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(61)92427-8","article-title":"Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia","volume":"278","author":"Magnus","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.det.2014.03.001_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2014.03.001_bib14","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1172\/JCI111616","article-title":"Activation of the complement system in patients with porphyrias after irradiation in\u00a0vivo","volume":"74","author":"Lim","year":"1984","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.det.2014.03.001_bib15","first-page":"148","article-title":"Molecular and cellular mechanisms of porphyrin photosensitization","volume":"3","author":"Poh-Fitzpatrick","year":"1986","journal-title":"Photodermatol"},{"key":"10.1016\/j.det.2014.03.001_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0738-081X(85)90034-3","article-title":"Porphyrin-sensitized cutaneous photosensitivity: pathogenesis and treatment","volume":"3","author":"Poh-Fitzpatrick","year":"1985","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/1011-1344(91)80015-A","article-title":"Mechanisms of photosensitivity in porphyric patients with special emphasis on erythropoietic protoporphyria","volume":"10","author":"Brun","year":"1991","journal-title":"J\u00a0Photochem Photobiol B"},{"key":"10.1016\/j.det.2014.03.001_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archderm.1973.01620200007002","article-title":"Cutaneous changes in the porphyrias. A microscopic study","volume":"107","author":"Epstein","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib19","first-page":"593","article-title":"Congenital porphyria","volume":"67","author":"Sneddon","year":"1974","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.det.2014.03.001_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archderm.1974.01630090061013","article-title":"Congenital erythropoietic porphyria. An autopsy report","volume":"110","author":"Bhutani","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib21","first-page":"394","article-title":"Cyclophosphamide and congenital erythropoietic porphyria","volume":"2","author":"Bhutani","year":"1985","journal-title":"Photodermatol"},{"key":"10.1016\/j.det.2014.03.001_bib22","first-page":"15","article-title":"Congenital erythropoietic porphyria in two siblings","volume":"11","author":"Jacobo","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2014.03.001_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.1980.01640290053010","article-title":"A\u00a0plasma pophyrin fluorescence marker for variegate porphyria","volume":"116","author":"Poh-Fitzpatrick","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib24","first-page":"932","article-title":"A\u00a0micromethod for free erythrocyte porphyrins: the FEP test","volume":"81","author":"Piomelli","year":"1973","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.det.2014.03.001_bib25","first-page":"S1","article-title":"Diagnosis of porphyria- recommended methods for peripheral laboratories","volume":"13","author":"Blake","year":"1992","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.det.2014.03.001_bib26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/clinchem\/31.7.1163","article-title":"Rapid procedure for fecal porphyrin assay","volume":"31","author":"Lockwood","year":"1985","journal-title":"Clin Chem"},{"key":"10.1016\/j.det.2014.03.001_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(84)90192-X","article-title":"Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias","volume":"139","author":"Lim","year":"1984","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.det.2014.03.001_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/0004563212473278","article-title":"Role of genetic testing in the management of patients with inherited porphyria and their families","volume":"50","author":"Whatley","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.det.2014.03.001_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.2008.08616.x","article-title":"Serum 25-hydroxyvitamin D in erythropoietic protoporphyria","volume":"159","author":"Holme","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2133.2006.07472.x","article-title":"Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life","volume":"155","author":"Holme","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-4-19","article-title":"Erythropoietic protoporphyria","volume":"4","author":"Lecha","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.det.2014.03.001_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng809","article-title":"The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH","volume":"30","author":"Gouya","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.det.2014.03.001_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/498620","article-title":"Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria","volume":"78","author":"Gouya","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2014.03.001_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.det.2014.03.001_bib35","first-page":"118","article-title":"The molecular genetics of erythropoietic protoporphyria","volume":"55","author":"Elder","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.det.2014.03.001_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2119\/molmed.2012.00340","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol Med"},{"key":"10.1016\/j.det.2014.03.001_bib37","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1182\/blood-2007-04-088120","article-title":"Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria","volume":"110","author":"Holme","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.det.2014.03.001_bib38","first-page":"1009","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management","volume":"56","author":"Anstey","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.det.2014.03.001_bib39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jama.1974.03230330034017","article-title":"Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria","volume":"228","author":"Mathews-Roth","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.det.2014.03.001_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2133.1977.tb14273.x","article-title":"The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial","volume":"97","author":"Corbett","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1365-2133.1995.tb16955.x","article-title":"Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses","volume":"132","author":"Collins","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.12714","article-title":"Narrowband UVB phototherapy in erythropoietic protoporphyria: case series","author":"Sivaramakrishnan","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJMc0805682","article-title":"An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria","volume":"60","author":"Harms","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2014.03.001_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1988.tb07102.x","article-title":"Erythropoietic protoporphyria exacerbated by oral iron therapy","volume":"119","author":"Milligan","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib45","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/lt.20620","article-title":"Liver transplantation for erythropoietic protoporphyria liver disease","volume":"11","author":"McGuire","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.det.2014.03.001_bib46","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/lt.21527","article-title":"Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria","volume":"14","author":"Wahlin","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.det.2014.03.001_bib47","series-title":"Handbook of porphyrin science","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1142\/9789814407755_0028","article-title":"Clinical and molecular epidemiology of the porphyrias","author":"Badminton","year":"2013"},{"key":"10.1016\/j.det.2014.03.001_bib48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2133.2007.08064.x","article-title":"Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene","volume":"157","author":"Mendez","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015550310007454","article-title":"Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status","volume":"83","author":"Bygum","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2014.03.001_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1373\/clinchem.2008.117432","article-title":"Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies","volume":"55","author":"Aarsand","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.det.2014.03.001_bib51","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1182\/blood-2008-02-138222","article-title":"Down-regulation of hepcidin in porphyria cutanea tarda","volume":"112","author":"Ajioka","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.det.2014.03.001_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bcmd.2011.07.006","article-title":"Uroporphyria in the Cyp1a2-\/- mouse","volume":"47","author":"Phillips","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.det.2014.03.001_bib53","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A\u00a0porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.det.2014.03.001_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cgh.2009.11.017","article-title":"Associations among behavior-related susceptibility factors in porphyria cutanea tarda","volume":"8","author":"Jalil","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.det.2014.03.001_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis","volume":"39","author":"Gisbert","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.det.2014.03.001_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MD.0b013e3181d50928","article-title":"Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients","volume":"89","author":"Munoz-Santos","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.det.2014.03.001_bib57","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","article-title":"Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda","volume":"95","author":"Bulaj","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.det.2014.03.001_bib58","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.21885","article-title":"Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analysis including 66000 cases and 226000 controls","volume":"46","author":"Ellervik","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.det.2014.03.001_bib59","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.det.2014.03.001_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0923-1811(94)90092-2","article-title":"Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload","volume":"7","author":"Valls","year":"1994","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.det.2014.03.001_bib61","first-page":"565","article-title":"Studies on in\u00a0vitro formation of complexes between porphyrins and chloroquine","volume":"6","author":"Chinarro","year":"1983","journal-title":"Biochem Int"},{"key":"10.1016\/j.det.2014.03.001_bib62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2340\/00015555-0260","article-title":"Porphyria cutanea tarda: effects and risk factors for hepatotoxicity from high-dose chloroquine treatment","volume":"87","author":"Rossmann-Ringdahl","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2014.03.001_bib63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0168-8278(01)00160-X","article-title":"Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease","volume":"35","author":"Francanzani","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.det.2014.03.001_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2133.2004.06120.x","article-title":"A\u00a0systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family","volume":"151","author":"Hift","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2796.1997.00189.x","article-title":"Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France","volume":"242","author":"Nordmann","year":"1997","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.det.2014.03.001_bib66","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116348","article-title":"Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen","volume":"91","author":"Meissner","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.det.2014.03.001_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2007-1007139","article-title":"Acute porphyrias: pathogenesis of neurological manifestations","volume":"18","author":"Meyer","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.det.2014.03.001_bib68","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-154-8-201104190-00015","article-title":"Liver transplantation from donors with acute intermittent porphyria","volume":"154","author":"Dowman","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.det.2014.03.001_bib69","first-page":"229","article-title":"Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood","volume":"46","author":"Brodie","year":"1977","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.det.2014.03.001_bib70","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.md.0000152454.56435.f3","article-title":"An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity","volume":"84","author":"Hift","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.det.2014.03.001_bib71","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1001\/archinte.1993.00410170078008","article-title":"Early administration of heme arginate for acute porphyric attacks","volume":"153","author":"Mustajoki","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.det.2014.03.001_bib72","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10545-005-4561-1","article-title":"Anxiety and depression in the acute porphyrias","volume":"28","author":"Millward","year":"2005","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.det.2014.03.001_bib73","first-page":"72","article-title":"Neurological manifestations of acute intermittent porphyria","volume":"55","author":"Pischik","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.det.2014.03.001_bib74","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jcp.54.7.500","article-title":"ACP best practice no 165: front line tests for the investigation of suspected porphyria","volume":"54","author":"Deacon","year":"2001","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.det.2014.03.001_bib75","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1373\/clinchem.2008.122564","article-title":"Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene","volume":"55","author":"Whatley","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.det.2014.03.001_bib76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0004563212474555","article-title":"Best practice guidelines on clinical management of acute attacks of porphyria and their complications","volume":"50","author":"Stein","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.det.2014.03.001_bib77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.det.2014.03.001_bib78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2796.1994.tb01279.x","article-title":"Hypertension and renal disease in patients with acute intermittent porphyria","volume":"236","author":"Andersson","year":"1994","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.det.2014.03.001_bib79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2796.2000.00743.x","article-title":"Renal symptomatology in patients with acute intermittent porphyria. A population-based study","volume":"248","author":"Andersson","year":"2000","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.det.2014.03.001_bib80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.0954-6820.1984.tb05005.x","article-title":"Hepatocellular carcinoma in patients with acute intermittent porphyria","volume":"215","author":"Lithner","year":"1984","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.det.2014.03.001_bib81","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0168-8278(00)80097-5","article-title":"Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors","volume":"32","author":"Andant","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.det.2014.03.001_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01213085","article-title":"Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2->q26.3","volume":"87","author":"Astrin","year":"1991","journal-title":"Hum Genet"},{"key":"10.1016\/j.det.2014.03.001_bib83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/geno.2000.6373","article-title":"Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression","volume":"70","author":"Aizencang","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.det.2014.03.001_bib84","first-page":"53","article-title":"Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype","volume":"55","author":"Ged","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.det.2014.03.001_bib85","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2012.11160.x","article-title":"Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib86","series-title":"The metabolic and molecular basis of inherited disease","first-page":"2991","article-title":"Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias","author":"Anderson","year":"2001"},{"key":"10.1016\/j.det.2014.03.001_bib87","first-page":"121","article-title":"Biochemical diagnosis of a fatal case of Gunther's disease in a newborn with hydrops foetalis","volume":"31","author":"Verstraeten","year":"1993","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.det.2014.03.001_bib88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s100240010143","article-title":"Congenital erythropoietic porphyria: prenatal diagnosis and autopsy findings in two sibling fetuses","volume":"4","author":"Daikha-Dahmane","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.det.2014.03.001_bib89","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2002.03557.x","article-title":"Congenital erythropoietic porphyria: advances in pathogenesis and treatment","volume":"117","author":"Desnick","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.det.2014.03.001_bib90","series-title":"The porphyrin handbook","first-page":"43","article-title":"Congenital erythropoietic porphyria","author":"De Verneuil","year":"2003"},{"key":"10.1016\/j.det.2014.03.001_bib91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1600-0781.2006.00231.x","article-title":"School in photodermatology: Smith-Lemli-Opitz syndrome","volume":"22","author":"Anstey","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.det.2014.03.001_bib92","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1365-2133.2012.11154.x","article-title":"A\u00a0management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib93","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/0140-6736(91)93198-I","article-title":"Bone-marrow transplantation for congenital erythropoietic porphyria","volume":"337","author":"Kaufman","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.det.2014.03.001_bib94","first-page":"217","article-title":"Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther\u2019s disease)","volume":"18","author":"Zix-Kieffer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.det.2014.03.001_bib95","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3476(96)70082-3","article-title":"Correction of\u00a0congenital erythropoietic porphyria by bone marrow transplantation","volume":"129","author":"Thomas","year":"1996","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.det.2014.03.001_bib96","first-page":"114","article-title":"Allogeneic bone marrow transplantation in congenital erythropoietic porphyria. Gunther\u2019s disease","volume":"125","author":"Lagarde","year":"1998","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.det.2014.03.001_bib97","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1182\/blood.V92.11.4053","article-title":"Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation","volume":"92","author":"Tezcan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.det.2014.03.001_bib98","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1702738","article-title":"Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature","volume":"27","author":"Shaw","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.det.2014.03.001_bib99","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mjd.2001.114730","article-title":"Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation","volume":"45","author":"Harada","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00431-004-1575-x","article-title":"Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Gunther disease)","volume":"164","author":"Dupuis-Girod","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.det.2014.03.001_bib101","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2006-06-022848","article-title":"Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria","volume":"109","author":"Phillips","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.det.2014.03.001_bib102","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2006.07699.x","article-title":"Allogeneic bone marrow transplantation in a 7-year-old girl with congenital erythropoietic porphyria: a treatment dilemma","volume":"156","author":"Taibjee","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-3046.2007.00842.x","article-title":"Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria","volume":"12","author":"Faraci","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.det.2014.03.001_bib104","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.annder.2010.06.018","article-title":"Congenital erythropoeietic porphyria treated by haematopoietic stem cell allograft","volume":"137","author":"Lebreuilly-Sohyer","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.det.2014.03.001_bib105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1525-1470.2010.01376.x","article-title":"Severe neonatal congenital erythropoietic porphyria","volume":"28","author":"Hogeling","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0378-6323.90963","article-title":"Bone marrow transplantation improves symptoms of congenital erythropoietic porphyria even when done post puberty","volume":"78","author":"Singh","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.det.2014.03.001_bib107","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000029857","article-title":"Congenital erythropoietic porphyria","volume":"11","author":"Fritsch","year":"1998","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1016\/j.det.2014.03.001_bib108","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(84)92298-0","article-title":"Homozygous variegate porphyria","volume":"1","author":"Korda","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.det.2014.03.001_bib109","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(77)90386-5","article-title":"Homozygous case of hereditary coproporphyria","volume":"2","author":"Grandchamp","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.det.2014.03.001_bib110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1600-0625.2006.00464.x","article-title":"Dual porphyrias revisited","volume":"15","author":"Poblete-Gutierrez","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2014.03.001_bib111","series-title":"The porphyrin handbook","first-page":"67","article-title":"Porphyria cutanea tarda and related disorders","author":"Elder","year":"2003"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863514000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863514000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T18:18:03Z","timestamp":1597774683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863514000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0733863514000163"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2014.03.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cutaneous Porphyrias","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}